Across America, a quiet public health emergency is unfolding one closed pharmacy at a time. CVS, Walgreens, and Rite Aid have collectively shuttered over 5,000 locations since 2019, with closures concentrated overwhelmingly in the communities that can least afford to lose them: low-income neighborhoods, rural towns, and predominantly Black and Latino ZIP codes.
These aren't just retail closures — they're the systematic dismantling of healthcare infrastructure in America's most vulnerable communities. When the corner pharmacy closes, it takes with it prescription access, vaccines, health screenings, and often the only healthcare touchpoint for miles around.
The Geography of Abandonment
The pattern of pharmacy closures follows a predictable logic of corporate profit maximization and racial disinvestment. A 2023 analysis by GoodRx found that pharmacy closures were three times more likely in majority-Black neighborhoods compared to majority-white areas. Rural communities, already underserved by healthcare infrastructure, have lost nearly 20% of their pharmacies since 2010.
In Chicago's South Side, residents of predominantly Black neighborhoods now travel an average of 2.1 miles to reach the nearest pharmacy, compared to 0.8 miles in majority-white North Side neighborhoods. The closure of a Walgreens in the Bronzeville neighborhood left 15,000 residents without a nearby pharmacy, forcing many to make hour-long bus trips to fill prescriptions.
Rural America faces an even starker reality. In towns across Mississippi, Alabama, and West Virginia, the local pharmacy closure often means the nearest prescription access is 30 or 40 miles away. For elderly residents without reliable transportation, this distance can be insurmountable.
The Corporate Calculus of Community Abandonment
Pharmacy chains defend these closures as necessary responses to changing market conditions, declining reimbursement rates, and the growth of online prescription delivery. But this explanation obscures the racial and economic logic driving closure decisions.
Corporate pharmacy chains use sophisticated algorithms that weigh factors including average household income, insurance mix, and prescription volume when determining which locations to shutter. These models systematically undervalue pharmacies in low-income communities, where customers may have Medicaid coverage (which reimburses at lower rates) or pay cash for prescriptions.
The result is a form of healthcare redlining. Communities with higher poverty rates, larger Black and Latino populations, and more Medicaid beneficiaries are deemed less profitable and marked for closure. Wealthier, whiter neighborhoods retain their convenient pharmacy access while poor communities of color lose theirs.
CVS, which operates over 9,000 locations nationwide, closed 244 stores in 2022 alone. Internal company documents obtained through litigation reveal that closure decisions heavily weighted "demographic factors" and "payer mix" — euphemisms for the racial and economic characteristics of surrounding neighborhoods.
Beyond Prescriptions: The Full Scope of Lost Services
Pharmacies serve as much more than prescription dispensaries, particularly in underserved communities. They provide immunizations, health screenings, basic medical supplies, and often serve as informal health information hubs where community members seek advice from trusted pharmacists.
During the COVID-19 pandemic, pharmacy closures became a matter of life and death. Communities that lost their pharmacies had significantly lower vaccination rates, not because residents were vaccine-hesitant, but because they lacked convenient access. A study by researchers at Northwestern University found that pharmacy closures were associated with a 10% decrease in flu vaccination rates and a 15% decrease in childhood immunization compliance.
For people managing chronic conditions like diabetes, hypertension, or heart disease, pharmacy access directly impacts health outcomes. When patients can't easily refill prescriptions, medication adherence plummets. Emergency room visits increase. Preventable hospitalizations spike.
The human cost is measured in insulin rationing by diabetics who can't afford the time and transportation to reach distant pharmacies. It's seniors skipping blood pressure medications because the pharmacy closure made refills too complicated. It's parents unable to get antibiotics for sick children because the nearest pharmacy is now an hour away.
The Insurance Industry's Role in Accelerating Closures
The pharmacy desert crisis has been accelerated by the insurance industry's aggressive cost-cutting measures. Pharmacy benefit managers (PBMs) — middlemen who negotiate drug prices between insurers and pharmacies — have systematically reduced reimbursement rates while imposing additional administrative burdens on independent pharmacies.
PBMs like CVS Caremark, Express Scripts, and OptumRx control over 80% of the prescription drug market. They use their leverage to favor their own pharmacy chains while squeezing independent competitors. When a local pharmacy can't afford to stay open because insurance reimbursements don't cover operating costs, communities lose their most accessible healthcare provider.
This consolidation benefits corporate pharmacy chains and PBMs at the expense of community health. The same companies that profit from pharmacy closures also operate the insurance plans and prescription benefits that make those closures financially necessary.
State and Federal Inaction in the Face of Crisis
Despite overwhelming evidence of the public health impact, federal and state governments have largely ignored the pharmacy desert crisis. The Federal Trade Commission has begun investigating PBM practices, but has taken no concrete action to prevent closures in underserved communities.
Some states have attempted piecemeal solutions. North Dakota requires 90 days' notice before pharmacy closures. California provides small grants to help rural pharmacies stay open. But these measures are insufficient to address the scale of the problem.
What's needed is comprehensive federal action: antitrust enforcement against PBM consolidation, requirements for community impact assessments before pharmacy closures, and public funding to ensure pharmacy access in underserved areas.
Community Responses and Alternative Models
Facing government inaction, some communities are developing their own solutions. In rural Iowa, community health centers have opened their own pharmacies to serve patients after corporate chains departed. In Detroit, a nonprofit organization launched a mobile pharmacy program to reach residents in pharmacy desert neighborhoods.
These community-driven initiatives prove that alternative models are possible. But they shouldn't be necessary. Access to prescription medications is a basic healthcare need that shouldn't depend on ZIP code or the profit calculations of corporate chains.
The Civil Rights Dimension
The concentration of pharmacy closures in Black and rural communities isn't coincidental — it's the predictable result of healthcare systems that treat access as a commodity rather than a right. When corporate algorithms systematically devalue communities based on race and income, the result is a form of healthcare apartheid.
This is why pharmacy desert advocacy increasingly frames the issue in civil rights terms. Equal access to healthcare services, including prescription medications, is fundamental to equal citizenship. When entire communities are abandoned by corporate pharmacy chains, it represents a violation of basic civil rights principles.
A Public Health Emergency Hiding in Plain Sight
The pharmacy desert crisis represents everything wrong with America's healthcare system: corporate profit prioritized over community need, racial and economic segregation embedded in service delivery, and government unwillingness to ensure basic healthcare access.
Every pharmacy closure in a low-income or rural community represents a policy choice — a decision that some Americans don't deserve convenient access to the medications that keep them alive and healthy.
Until we treat healthcare access as a public good rather than a private commodity, the pharmacy desert crisis will continue expanding, leaving America's most vulnerable communities further behind.
